Intelligence · Clinical Development
Pipeline search results
Programs matching “omid” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 143 pipeline programs matching "omid" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Dexmedetomidine
Hospital Authority, Hong Kong
CABG
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Renal Failure
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Benign Neoplasm of Vocal Fold - Glottis
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Old Age
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiac Surgery
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Anxiety
1 trial -
Dexmedetomidine Injection
The First People's Hospital of Lianyungang
Coronary Disease
1 trial -
Dexmedetomidine group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colonoscopy
1 trial -
Dexmedetomidine injection
United Therapeutics Europe Ltd
Delirium in Old Age
1 trial -
Dexmedetomidine ropivacaine
The First People's Hospital of Lianyungang
Pharmacological Action
1 trial -
Dexmedetomidine supplemented morphine analgesia
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Elderly
1 trial -
Dexmedetomidine-Esketamine Combination
The First People's Hospital of Lianyungang
Aged
1 trial -
Dexmedetomidine-esketamine combination
The First People's Hospital of Lianyungang
Liver Cancer
1 trial -
Etomidate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postoperative Complications
1 trial -
Intravenous dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aneurysm Cerebral
1 trial -
Leflunomide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ANCA Associated Vasculitis
1 trial -
Lenalidomide
The First People's Hospital of Lianyungang
Diffuse Large B Cell Lymphoma
1 trial -
Thalidomide
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma
1 trial -
dexmedetomidine
Sana Biotechnology
Laparoscopic Cholecystectomy
1 trial -
dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Anesthesia
1 trial -
dexmedetomidine
The First People's Hospital of Lianyungang
Children
1 trial -
etomidate anesthesia
Xiyuan Hospital of China Academy of Chinese Medical Sciences
General Anesthesia
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.